Botulinum toxin warning

Safety information regarding botulinum toxin products (Botox, Dysport, NeuroBloc and Vistabel) has been issued by the manufacturers following discussion with European regulatory authorities, including the MHRA.

There have been very rare reports of serious adverse effects related to the distant spread of botulinum toxin, including muscle weakness, dysphagia or aspiration pneumonia.

Patients and carers should be informed about the risk of toxin spread and advised to seek immediate medical attention if swallowing, speech or respiratory disorders arise.

Further information: The Medicines and Healthcare products Regulatory Agency

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more